You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, T-Cell

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Aplastic Anemia Trial run by the NHLBI (Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Cohort 2: hATG, CsA, EPAG Day 14 to

Recruiting
Has Results
  • Severe Aplastic Anemia
  • Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 5, 2022

GI Motility Disorder Trial in Leuven (Corticotropin-release hormone)

Recruiting
  • GI Motility Disorder
  • Corticotropin-release hormone
  • Leuven, Belgium
    I-Hsuan Huang
Oct 7, 2021

Melasma Trial in Abbottabad, Abbottabad (Tranexamic acid, Platelets rich plasma)

Completed
  • Melasma
  • Tranexamic acid
  • Platelets rich plasma
  • Abbottabad, Khyber Pakhtun Khwaa, Pakistan
  • +2 more
May 30, 2023

Sickle Cell Disease Trial in Worldwide (IMR-687, Placebo)

Terminated
  • Sickle Cell Disease
  • Birmingham, Alabama
  • +48 more
May 9, 2022

Pancreatic Calcium Handling in Islet Beta Cells in Type 1

Completed
  • Type 1 Diabetes
    • Edinburgh, Scotland, United Kingdom
      University of Edinburgh
    Mar 25, 2022

    Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)

    Recruiting
    • Metastatic Squamous Non-Small Cell Lung Carcinoma
    • Cabozantinib 40 MG
    • Pembrolizumab 200mg
    • Chicago, Illinois
      University of Illinois at Chicago
    Jan 20, 2023

    MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Duarte, California
    • +46 more
    Jan 20, 2023

    Crohn Disease Trial in Seattle (procedure, drug, other, radiation)

    Terminated
    Has Results
    • Crohn Disease
    • Allogeneic Bone Marrow Transplantation
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 3, 2020

    Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy

    Not yet recruiting
    • X-linked Adrenoleukodystrophy
    • brainQuant module of brainTale-care platform
    • (no location specified)
    Jun 12, 2023

    Predictors of Failed Thrombolysis in Acute Myocardial Infarction

    Not yet recruiting
    • STEMI - ST Elevation Myocardial Infarction
    • Successfull thrombolysis
    • (no location specified)
    Apr 20, 2022

    Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)

    Recruiting
    • Small Cell Lung Cancer
    • AL8326 low dose group
    • +2 more
    • Saint Louis, Missouri
      Siteman cancer center, Washington University
    Nov 1, 2022

    Advanced Solid Cancers, Hematologic Cancers Trial in New York, San Antonio, Toronto (SRF231)

    Completed
    • Advanced Solid Cancers
    • Hematologic Cancers
    • New York, New York
    • +2 more
    Oct 19, 2020

    Enablers and Barriers to Hydroxyurea Use for Sickle Cell Disease

    Recruiting
    • Sickle Cell Disease
    • questionnaires (surveys)
    • Kingston, Saint Andrew, Jamaica
      Sickle Cell Unit - Caribbean Institute for Health Research
    Jun 16, 2023

    Microenvironment of Lung Cancer and Exploration of Mechanism of

    Recruiting
    • Lung Cancer
    • Multiomics analysis
    • Yiwu, Zhejiang, China
      The Fourth Affiliated Hospital of Zhejiang University
    Dec 16, 2022

    Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma Trial in Seattle (Bomedemstat, Atezolizumab)

    Recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • Limited Stage Lung Small Cell Carcinoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 30, 2022

    Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

    Recruiting
    • Acute Myeloid Leukemia
    • allogenic NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Prostate Cancer Metastatic Trial in Duarte, Marina Del Rey, Honolulu (Atezolizumab1200 mg IV, Sipuleucel-T)

    Completed
    • Prostate Cancer Metastatic
    • Duarte, California
    • +2 more
    May 24, 2021

    Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Jun 8, 2023

    Other Cancer Trial in United States (Shared Care, Standard Care)

    Completed
    • Other Cancer
    • Shared Care
    • Standard Care
    • Stamford, Connecticut
    • +8 more
    Nov 1, 2022

    Hepatitis B, Chronic Trial in Worldwide (Midazolam, Placebo, RO7049389)

    Completed
    • Hepatitis B, Chronic
    • Herston, Queensland, Australia
    • +20 more
    Jul 7, 2022

    Metastatic Cancer Trial in Spain (Tumor and Blood sample collection)

    Recruiting
    • Metastatic Cancer
    • Tumor and Blood sample collection
    • Badalona, Barcelona, Spain
    • +14 more
    Jan 23, 2023

    Uveal Melanoma Trial in Germany (Autologous Dendritic Cells loaded with autologous Tumor RNA)

    Active, not recruiting
    • Uveal Melanoma
    • Autologous Dendritic Cells loaded with autologous Tumor RNA
    • Erlangen, Bayern, Germany
    • +7 more
    Nov 29, 2022

    Electromagnetic Radiation (5GFR2) Trial (5GFR2 non ionizing EMW exposure)

    Not yet recruiting
    • Electromagnetic Radiation (5GFR2)
    • 5GFR2 non ionizing EMW exposure
    • (no location specified)
    Jun 28, 2023

    Lung Cancer, Metastatic Cancer Trial in Detroit (Cryotherapy (PTC), Prednisone)

    Completed
    Has Results
    • Lung Cancer
    • Metastatic Cancer
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Oct 29, 2022

    Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Worldwide (palbociclib, Cetuximab, Placebo)

    Completed
    Has Results
    • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    • La Jolla, California
    • +70 more
    Oct 10, 2022